Spectroscopic and molecular docking studies reveal binding characteristics of nazartinib (EGF816) to human serum albumin
The interactions of novel anti-cancer therapeutic agents with the different plasma and tissue components, specifically serum albumins, have lately gained considerable attention due to the significant influence of such interactions on the pharmacokinetics and/or -dynamics of this important class of t...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
The Royal Society
2020-01-01
|
| Цуврал: | Royal Society Open Science |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsos.191595 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|